The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1586309
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP05010806.7
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
21/09/2001
Grant date:
24/02/2010
EP Publication Date:
19/10/2005
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
19/09/2019
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
24/02/2010
EP B1 Publication Date:
24/02/2010
EP B2 Publication Date:
EP B3 Publication Date:
18/09/2019
Description Translation B1 Received Date:
20/05/2010
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/09/2021
Lapsed By Expiration Date:
21/09/2021
Patent Validated Date:
02/10/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
14/11/2017
Name:
TOLMAR Therapeutics, Inc.
Address:
701 Centre Avenue, 80526, FORT COLLINS, CO , United States of America (US)
Historical Applicant/holder
From:
24/02/2010
To:
14/11/2017
Name:
QLT USA, Inc.
Address:
2579 Midpoint Drive, FORT COLLINS, CO 80525, United States of America (US)